UPDATE: Wells Fargo Reinstates Merck (MRK) at Overweight

Go back to UPDATE: Wells Fargo Reinstates Merck (MRK) at Overweight

Merck Prices $8.0 Billion Debt Offering

December 7, 2021 7:18 PM EST

KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today priced an $8.0 billion public offering of five series of senior unsecured notes (collectively, the notes). The notes include:

$1.5 billion of 1.700% notes due 2027 (the 2027 notes)

$1.0 billion of 1.900% notes due 2028 (the sustainability notes)

$2.0 billion of 2.150% notes due 2031 (the 2031 notes)

$2.0 billion of 2.750% notes due 2051 (the 2051 notes)

$1.5 billion of 2.900% notes due 2061 (the 2061 notes)

Merck intends to use the net proceeds from the offering of the 2027 notes, the 2031... More

Merck Announces Additional $150M Investment Through 2025 to Help End Maternal Mortality Inequities

December 7, 2021 6:15 AM EST

KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today an additional $150 million commitment through Merck for Mothers to further advance the initiatives mission of helping create a world where no woman has to die giving life. This investment builds on a... More